Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
aspirin, Quantity: 100 mg
Tianda Pharmaceuticals Australia Pty Ltd
Aspirin
Tablet, enteric coated
Excipient Ingredients: pregelatinised maize starch; microcrystalline cellulose; stearic acid; colloidal anhydrous silica; titanium dioxide; purified talc; triethyl citrate; sodium lauryl sulfate; methacrylic acid copolymer; sodium bicarbonate; hypromellose; triacetin; sunset yellow FCF aluminium lake; macrogol 400; brilliant scarlet 4R aluminium lake
Oral
28, 84, 168
Not scheduled. Not considered by committee, (S2) Pharmacy Medicine
For the treatment of patients with known cardiovascular or cerebrovascular disease, as an antiplatelet agent for prophylaxis against acute myocardial infarction, unstable angina, transient ischaemic attack and cerebrovascular accident (stroke).
Visual Identification: Double convex shaped cylindrical tablets with enteric and red film coating; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2010-05-13